Deployment and Upgrades for Rare Disease Products

Data Characteristics in the Rare Disease Domain

Data in the rare disease domain originates primarily from authoritative medical journals, clinical trial reports, disease registries, gene sequencing databases, and patient communities. Data updates are relatively infrequent, typically on a quarterly or annual basis. However, new drug approvals or clinical research breakthroughs trigger concentrated updates. Document structures are predominantly unstructured text, such as case descriptions and research papers. Structured data, like gene mutation sites, disease subtypes, and efficacy indicators, supplements this. Fields often include disease names (frequently English abbreviations or full names), gene loci (e.g., exon, cDNA numbers), protein expression levels (units nM, μg/mL), patient inclusion criteria, and clinical endpoints (e.g., PFS, OS).

Constraints on Deployment and Upgrades from These Characteristics

The low update frequency of rare disease data means the knowledge base does not require overly frequent full updates after deployment. However, the incremental update mechanism must be robust. The prevalence of unstructured text documents demands high-quality text segmentation and vector embedding models. These models must accurately capture medical terminology and contextual relationships. Identifying and extracting specific fields like gene loci and protein expression requires customized entity recognition rules or pre-trained models to ensure information accuracy. Deployment needs sufficient storage and computing resources to handle the computational overhead of high-quality embedding models. During upgrades, especially for model or core component version upgrades, strict regression testing is necessary. This ensures that the understanding and recall of rare disease-specific terminology remain unaffected, preventing critical information loss due to model iterations.

Configuration Guidelines

Configuration Item	Recommended Value	Rationale
`UPLOAD_FILE_MAX_SIZE`	`500 MB`	Rare disease research documents often contain high-resolution images or large amounts of text, leading to large file sizes.
`PARSE_FILE_TIMEOUT_SECONDS`	`600 seconds`	Processing complex structures or extremely long medical reports can result in extended file parsing times.
`Segment Length`	`800–1200 characters`	Ensures that rare disease-related concepts and contextual information remain within the same segment, preventing truncation of critical information.
`Similarity Threshold`	`0.8`	Rare disease consultations demand high accuracy. A high threshold helps recall more precise and relevant results, reducing noise.
`Recall Count`	`Top 10 items`	Rare disease information is dense. Recalling more items ensures coverage of potential relevant knowledge points, improving the comprehensiveness of answers.
`maxContext`	Calibrate by actual measurement, `16k` or higher recommended	The pathological mechanisms of rare diseases are complex, requiring longer contextual understanding, especially when involving multi-gene and multi-symptom associations.

Common Pitfalls

embedding error during knowledge base construction: This typically occurs when special medical characters or overly long professional terms in segmented text cause the embedding model to fail. Review segmentation logic and cleansing rules.
Persistent Exception: 'usage' Key errors in group chats: This often happens after deployment due to incorrect API KEY configuration or outdated keys, leading to external large model API call failures or exceeding free quota limits.
Query results do not match expectations after creating a new knowledge base, lacking rare disease-specific information: This usually indicates improper Segment Length or Recall Count configuration, failing to effectively capture and display fine-grained rare disease-specific knowledge points.

Verification Steps

Upload a rare disease research report containing complex gene sequences or clinical data. Check if its segmentation is logically complete and free of obvious semantic breaks.
Query using rare disease-specific gene mutations or disease names. Verify the similarity scores of the recalled results and confirm that the recalled items cover core information.
Simulate user questions about treatment plans or diagnostic criteria for a specific rare disease. Evaluate the accuracy, completeness, and professionalism of the answers, especially regarding units of measurement and specialized terminology.

Note: The values provided are common starting points. Measure them against specific samples to determine optimal settings.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.